Atlas Arteria Earnings Calls

Dec 31, 2025
$0.197 (-1.45%)
Release date Feb 25, 2026
EPS estimate $0.200
EPS actual $0.197
EPS Surprise -1.45%
Revenue estimate 93.682M
Revenue actual 55.048M
Revenue Surprise -41.24%
Jun 30, 2025
$0.0485 (-59.60%)
Release date Aug 27, 2025
EPS estimate $0.120
EPS actual $0.0485
EPS Surprise -59.60%
Revenue estimate 115.405M
Revenue actual 50.776M
Revenue Surprise -56.00%
Mar 30, 2025
Release date May 15, 2025
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Dec 31, 2024
$0.0946 (-43.53%)
Release date Feb 27, 2025
EPS estimate $0.168
EPS actual $0.0946
EPS Surprise -43.53%
Revenue estimate -
Revenue actual 46.668M

Last 4 Quarters for Atlas Arteria

Below you can see how MAQAF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024 Missed
Release date Feb 27, 2025
Price on release $3.00
EPS estimate $0.168
EPS actual $0.0946
EPS surprise -43.53%
Date Price
Feb 21, 2025 $3.00
Feb 24, 2025 $3.00
Feb 25, 2025 $3.00
Feb 26, 2025 $3.00
Feb 27, 2025 $3.00
Feb 28, 2025 $3.00
Mar 03, 2025 $3.10
Mar 04, 2025 $3.10
Mar 05, 2025 $3.10
4 days before 0%
4 days after 3.33%
On release day 0%
Change in period 3.33%
Mar 30, 2025
Release date May 15, 2025
Price on release $3.57
EPS estimate -
EPS actual -
Date Price
May 09, 2025 $3.57
May 12, 2025 $3.57
May 13, 2025 $3.57
May 14, 2025 $3.57
May 15, 2025 $3.57
May 16, 2025 $3.57
May 19, 2025 $3.57
May 20, 2025 $3.57
May 21, 2025 $3.57
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Jun 30, 2025 Missed
Release date Aug 27, 2025
Price on release $3.50
EPS estimate $0.120
EPS actual $0.0485
EPS surprise -59.60%
Date Price
Aug 21, 2025 $3.50
Aug 22, 2025 $3.50
Aug 25, 2025 $3.50
Aug 26, 2025 $3.50
Aug 27, 2025 $3.50
Aug 28, 2025 $3.50
Aug 29, 2025 $3.05
Sep 02, 2025 $3.50
Sep 03, 2025 $3.50
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Dec 31, 2025 Missed
Release date Feb 25, 2026
Price on release $3.68
EPS estimate $0.200
EPS actual $0.197
EPS surprise -1.45%
Date Price
Feb 19, 2026 $3.39
Feb 20, 2026 $3.39
Feb 23, 2026 $3.39
Feb 24, 2026 $3.68
Feb 25, 2026 $3.68
Feb 26, 2026 $3.68
Feb 27, 2026 $3.68
Mar 02, 2026 $3.68
Mar 03, 2026 $3.68
4 days before 8.55%
4 days after 0%
On release day 0%
Change in period 8.55%

Atlas Arteria Earnings Call Transcript Summary of Q4 2025

Atlas Arteria reported steady operational performance in FY2025 with proportional toll revenue up 9.4% and proportional EBITDA up 9.3%, driven by traffic growth (notably France and Dulles Greenway), CPI-linked toll increases and favorable FX movements. Free cash flow per security was slightly down, mainly due to France's Temporary Supplemental Tax (TST). The board confirmed a distribution of $0.40 per security for 2025 and announced the same $0.40 distribution guidance for 2026. Management highlighted a refreshed leadership structure and a clarified strategy built on four pillars: strategy (portfolio optimization), partnerships, disciplined development (prioritizing distribution-accretive opportunities), and capital management. Key near-term focuses are unlocking value at existing assets (including Dulles Greenway rate-case activities), preparing for future French concession retenders (noting evolving concession size/duration and tax framework), disciplined pursuit of new OECD opportunities that complement the portfolio, and maintaining an optimal capital structure. The group maintains a strong corporate cash balance (~$151m) and active FX hedging on part of euro distributions (zero upfront cost, rolling 12-month program). Management expects growth-related corporate costs of roughly $5–10m p.a. over the next 2–3 years (funded from corporate cash), and sees capacity to return to their 90–110% free cash flow payout range once the TST impact abates. The balance sheet remains robust with $1.4bn of bonds issued across businesses in 2025 and ongoing refinancing assessment for 2026.

Atlas Arteria Earnings History

Earnings Calendar

FAQ

When is the earnings report for MAQAF?
Atlas Arteria Ltd. (MAQAF) has scheduled its earnings report for Aug 27, 2026 after the markets close.

What is the MAQAF price-to-earnings (P/E) ratio?
MAQAF P/E ratio as of Jun 22, 2026 (TTM) is 34.69.

What is the MAQAF EPS forecast?
The forecasted EPS (Earnings Per Share) for Atlas Arteria Ltd. (MAQAF) for the first fiscal quarter 2026 is $0.124.

What are Atlas Arteria Ltd.'s retained earnings?
On its balance sheet, Atlas Arteria Ltd. reported retained earnings of $55.05 million for the latest quarter ending Dec 31, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE